Resistance reverse effects of honokiol on multidrug resistance of U937/ADR cell line

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 29, Issue 9, 2009, Pages 1035-1039

  Xue, Fang ^a   Cheng, Zhi Yong ^b   Liang, Wen Tong ^b   Chen, Hao ^a   Wang, Su Yun ^a   Yao, Li ^a   Pan, Ling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b First Hospital of Baoding   (China)

Author keywords

Honokiol; Multidrug resistance; NF B; P gp; U937 ADR cell line

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; HONOKIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RHODAMINE 123;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG EXCRETION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77953425501     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chinese source
2. Grandage VL, Gale RE, Linch DC, et al. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways[J]. Leukemia, 2005, 19(4): 586-594.
3. Kuribara H, Stavinoha WB, Maruyama Y. Behavioral pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice[J]. J Pharm Pharmacol, 1998, 50(7): 819-826.
4. Fong WF, Tse AK, Poon KH, et al. Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid[J]. Int J Biochem Cell Biol, 2005, 37(2): 427-441.
5. Luo Y, Xu Y, Chen L, et al. Preparative purification of anti-tumor derivatives of honokiol by high-speed counter-current chromatography [J]. J Chromatogr A, 2008, 1178(1-2): 160-165.
6. Chinese source
7. Tran TT, Mittal A, Aldinger T, et al. The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells[J]. Biophys J, 2005, 88(1): 715-738.
8. Nadali F, Pourfathollah AA, Alimoghaddam K, et al. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells[J]. Hematology, 2007, 12(5): 393-401.
9. Xu D, Lu Q, Hu X. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol [J]. Cancer Lett, 2006, 243(2): 274-80.
10. Ishitsuka K, Hideshima T, Hamasaki M, et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and- independent apoptosis [J]. Blood, 2005, 106(5), 1794-1800.
11. Hu YD, Qian GS. The MDR of verpamil reversing to lung adnocarcinoma A549[J]. Cancer, 1996, 15(6): 417-419.
12. Chinese source
13. Bentires-Alj M, Barbu V, Fillet M, et al. NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells [J]. Oncogene, 2003, 22(1): 90-97.
14. Garg A, Aggarwal BB. Nuclear transcription factor-kappaB as a target for cancer drug development [J]. Leukemia, 2002, 16(6): 1053-1068.